
Theradaptiverevenue
Theradaptive is a privately held, clinical-stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology.
Theradaptive revenue
Theradaptive has not published its revenue. Growjo puts it at about $3.5M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $3.5MEST | Growjo estimate |
Theradaptive CEO & employees
Daniel Dimitri is CEO of Theradaptive. Theradaptive has 31 employees (September 2025, LinkedIn).
Theradaptive FAQ
What is Theradaptive's revenue?
Growjo estimates Theradaptive's revenue at about $3.5M a year (September 2025). The company hasn't published its own figure.
How many employees does Theradaptive have?
Theradaptive has 31 employees as of September 2025, according to LinkedIn.
Who is the CEO of Theradaptive?
Daniel Dimitri is the CEO of Theradaptive.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Theradaptive? Join the podcast